Eton Pharmaceuticals, Inc. - Common Stock (ETON)

59 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q1 2024.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7.18M shares of 26.8M outstanding shares and own 26.75% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.45M shares), VANGUARD GROUP INC (1.03M shares), Acuitas Investments, LLC (580K shares), Westside Investment Management, Inc. (574K shares), PARADIGM CAPITAL MANAGEMENT INC/NY (300K shares), BlackRock Inc. (283K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (253K shares), GEODE CAPITAL MANAGEMENT, LLC (234K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (199K shares), and Parkman Healthcare Partners LLC (199K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.